Thrombosis AustraliaThrombosis Australia is a central information and resource hub for the community, proudly brought to you by the Perth Blood Institute. Our Thrombosis Australia Advisory Panel consists of seven eminent Australian healthcare professionals who collectively bring a wealth of experience and knowledge to the Thrombosis Australia Initiative. Follow the link below to learn more! Thrombosis Australia Advisory Panel If you are a healthcare professional you can access the Thrombosis Australia Professionals site here: Thrombosis Australia Professionals About us About Thrombosis Tools & Resources Your Stories What's New What's On Get Involved Advisory Panel Thrombosis Australia is an initiative of the Perth Blood Institute, a not-for-profit organisation dedicated to improving the quality of life for people with blood disorders. Thrombosis Australia and Thrombosis Australia Professionals sit side by side to meet professional and community needs in the field of thrombosis. We have established an advisory panel to provide oversight and direction to Thrombosis Australia, to ensure that the information we provide is current and accurate. The panel consists of eminent healthcare professionals that collectively bring a wealth of experience and knowledge to the Thrombosis Australia Initiative. The breadth of their collective experience covers a range of clinical and academic interests relating to blood disorders, including distinguished editorial roles, clinical trial design and management, teaching, and extensive authorship. The advisory panel sets the benchmark for the quality, accuracy, and currency of information by critically evaluating and reviewing content, and offers dynamic perspectives and advice to maintain oversight of the purpose and usefulness of the Thrombosis Australia Initiative in the fight against venous thromboembolism. The panel is chaired by David Macey, member of the Perth Blood Institute's Board of Directors. Dr Jennifer Curnow MBBS, FRACP, FRCPA, PhD Dr Jennifer Curnow received her FRACP and FRCPA in Haematology in 2004/2005 and is the Director of Clinical Haematology for Western Sydney LHD at Westmead Hospital. Dr Curnow is a former president of the Thrombosis and Haemostasis Society of Australia (formerly the Australasian Society of Thrombosis and Haemostasis) and is chair of the THANZ Education subcommittee. Dr Curnow is also co-author of multiple national and state guidance documents for thrombosis and haemostasis. Dr Curnow chairs the NSW Clinical Excellence Commission Anticoagulant medicines working party. Prof Graeme J. Hankey MBBS MD FRCP FRCPEdin FRACP FAHA FESO FWSO FAAHMS Graeme Hankey is Professor of Neurology at The University of Western Australia, and a Consultant Neurologist at Sir Charles Gairdner Hospital. He is an Associate Editor of Circulation, Editorial Consultant for The Lancet Neurology, a consulting Editor of the International Journal of Stroke, and Section co-Editor for the Epidemiology, Outcomes, & Population Science section of Stroke. He is a Web of Science Highly Cited Researcher for 2017-2019, co-authoring 10 books and >900 research articles, with > 100,000 citations (h-index 121). Professor Shirley Jansen PhD FRACS FRCS MBChB Shirley Jansen is Professor of Vascular Surgery at Curtin University, and both Head of Department and Consultant Vascular and Endovascular Surgeon at Sir Charles Gairdner Hospital. She is Director of the Heart & Vascular Research Institute, Programme Lead Cardiovascular at Harry Perkins Institute for Medical Research and Adjunct Clinical Professor at the University of WA. Shirley has broad research interests in vascular and endovascular surgery with over 60 published research papers and 4 book chapters. She has extensive experience conducting clinical trials as primary investigator including first in man. Emeritus Professor David Macey BSc (Hons) PhD (Chair) A retired Professor of Animal Physiology, David is a contributing author to over 100 research papers, as well as multiple book chapters. Prior to his retirement, David held the positions of Director of Admissions at Murdoch University, Faculty Dean and Pro Vice Chancellor: Science and Engineering and Academic Chair for Medicine. He is currently Emeritus Professor at Murdoch and actively contributes to teaching and research at both Murdoch and Notre Dame Universities. David is a member of the PBI Board with responsibility for chairing the Advisory Panel. Dr Jamie Price FRACP FRCPA Dr Jamie Price graduated from UWA in 1973. Dr Price was a resident at Princess Margaret and Royal Perth Hospital and specialises in haematology. Dr Price was appointed Clinical Haematologist at PMH and worked in haematology and oncology for over 30 years. His special interests are in paediatric haematology, bleeding disorders, and thrombotic disorders. One of his major objectives was in the prophylaxis of haemophilia and the preservation of joint function in haemophiliac patients. Dr Peter Purnell MBBS FRACP FCSANZ Dr Purnell is a cardiovascular imaging specialist based in Perth, WA. He was previously Head of Department of Cardiology at Joondalup Health Campus and currently works in research and private practice. His primary clinical interests are in heart failure, coronary disease, valvular heart disease, stroke prevention in atrial fibrillation, and cardio-oncology. He set up GenesisCare Cardio-Oncology service in WA in 2018 for medical oncology, expanded in 2019 to cover radiation oncology. Dr Purnell is the founding Director of Joondalup Cardiovascular Trials Inc., an independent, not-for-profit research organisation. He is also Head of Research GenesisCare Cardiology Western Australia. Prof Huyen Tran MBBS (Hons) Master Clin Epi FRACP FRCPA Professor Huyen Tran is a Professor at Australian Centre for Blood Diseases, Monash University, and Director of the Ronald Sawers Haemophilia Treatment Centre and Clinical Thrombosis Service, The Alfred Hospital. Both of these organisations undertake research based on their specialisation. Prof Tran has over 75 publications in peer-reviewed journals, has been involved in clinical trials for 20 years and contributes to several advisory boards. He is Chair of the Australian Haemophilia Centre Director's Organisation, and Chair of the Clinical Trials Group of the Thrombosis and Haemostasis Society of Australia and New Zealand.